186
Participants
Start Date
July 23, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2030
Indocyanine green (ICG) injection for intraoperative lymph node imaging
Indocyanine Green (ICG) is used to guide the extent of D3 lymph node dissection during right hemicolectomy. After informed consent, participants randomized to the experimental group undergo bowel preparation and receive an endoscopic submucosal injection of ICG (0.25 mg/ml in saline) at two sites adjacent to the tumor one day prior to surgery. During surgery, near-infrared laparoscopic or robotic imaging systems detect the fluorescence emitted by ICG, guiding targeted D3 lymph node dissection at the origins of the ileocolic artery (ICA) and middle colic artery (MCA).
Standard Right Hemicolectomy (Non-ICG)
Participants in the control group undergo standard right hemicolectomy with D3 lymph node dissection without the use of Indocyanine Green (ICG) or fluorescence imaging. The extent of dissection is determined by conventional anatomical landmarks and the surgeon's clinical judgment.
NOT_YET_RECRUITING
Keimyung University Dongsan Medical Center, Daegu
RECRUITING
Kyungpook National University Chilgok Hospital, Daegu
RECRUITING
Chungnam National University Hospital, Daejeon
NOT_YET_RECRUITING
National Cancer Center Korea, Goyang
RECRUITING
Chonnam National University Hwasun Hospital, Hwasun
RECRUITING
Gachon University Gil Medical Center, Incheon
RECRUITING
Jeonbuk National University Hospital, Jeonju
NOT_YET_RECRUITING
Seoul National University Bundang Hospital, Seongnam
RECRUITING
Asan Medical Center, Seoul
NOT_YET_RECRUITING
Korea University Guro Hospital, Seoul
NOT_YET_RECRUITING
Kyung Hee University Hospital, Seoul
RECRUITING
St. Vincent's Hospital, The Catholic University of Korea, Suwon
RECRUITING
Pusan National University Yangsan Hospital, Yangsan
Pusan National University Yangsan Hospital
OTHER